Using Residual Newborn Blood Spots to Investigate CpG Methylation in Relation to Air Pollution and Congenital Heart Defects
Birth Defects Research · 2025
DOI: 10.1002/bdr2.2473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Birth Defects Research, 2025. Verfasst von Thomas J Luben und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, RTP, North Carolina, U…. Hauptthemen laut MEDLINE: DNA Methylation, CpG Islands, Air Pollution, Heart Defects, Congenital. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural EPA, NIEHS NIH HHS, CDC HHS.
Abstract (Originalsprache)
Background
The prevalence of tetralogy of Fallot (TOF), a common congenital heart defect, has increased over the last two decades.
Methods
Genome‐wide CpG methylation patterns were assessed and analyzed in relation to gestational air pollution exposure among 24 infants with TOF and 24 sex‐matched control infants without a birth defect from a North Carolina population‐based, case–control study of major structural birth defects (2006–2011). Air pollution exposure during obstetric weeks 3–8 was assigned based on self‐reported residence. DNA was extracted from residual newborn blood spots, and DNA methylation levels were measured using the Illumina EPIC Array.
Results
Cases had higher exposure to both PM 2 .5 and O 3 compared to controls. No specific CpG loci were statistically significantly associated with TOF status or air pollution exposure; however, we observed associations between TOF case status and DNA methylation at specific genomic regions with genes enriched for functions in metabolism. Additionally, there were significant regions that displayed differential DNA methylation in relation to air pollution exposure within genes involved in apoptosis, necrosis, inflammation, and immune response pathways.
Conclusions
Generally, air pollution exposure and TOF were associated with differential DNA methylation in distinct genes. These results highlight suggestive links between the environment, epigenome, and TOF to be further investigated in larger studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, RTP, North Carolina, USA.
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Epidemiology, Columbia University, New York, USA.
ORCID-Profile: Thomas J Luben, Andrew F Olshan
Förderung
- Intramural EPA
- NIEHS NIH HHS
- CDC HHS
- National Institute of Environmental Health Sciences
- Centers for Disease Control and Prevention
Zitieren
APA
Luben, T. J., Roell, K., Harrington, C. E., Stingone, J. A., Ward-Caviness, C. K., Desrosiers, T. A., Fry, R. C., & Olshan, A. F. (2025). Using Residual Newborn Blood Spots to Investigate CpG Methylation in Relation to Air Pollution and Congenital Heart Defects. Birth Defects Research. https://doi.org/10.1002/bdr2.2473
Vancouver
Luben TJ, Roell K, Harrington CE, Stingone JA, Ward-Caviness CK, Desrosiers TA, et al. Using Residual Newborn Blood Spots to Investigate CpG Methylation in Relation to Air Pollution and Congenital Heart Defects. Birth Defects Research. 2025. doi:10.1002/bdr2.2473
BibTeX
@article{Luben2025,
author = {Luben, Thomas J and Roell, Kyle and Harrington, Cailee E and Stingone, Jeanette A and Ward-Caviness, Cavin K and Desrosiers, Tania A and Fry, Rebecca C and Olshan, Andrew F},
title = {Using Residual Newborn Blood Spots to Investigate CpG Methylation in Relation to Air Pollution and Congenital Heart Defects},
journal = {Birth Defects Research},
year = {2025},
doi = {10.1002/bdr2.2473}
}
EUVIMED